Nektar Therapeutics reported $19.61M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
ALKERMES ALKS:US 244.58M 6.01M
Amgen AMGN:US $ 5097M 208M
Astrazeneca AZN:US 6.04B 15M
Baxter International BAX:US $ 1343M 101M
Biocryst Pharmaceuticals BCRX:US $ 40.38M 9.24M
Biogen BIIB:US $ 2267.1M 48.2M
Bluebird Bio BLUE:US $ 2.97M 10.8M
Bristol Myers Squibb BMY:US $ 9333M 81M
Dr.Reddys Laboratories DRRD:IN 37.59B 5.16B
Eisai 4523:JP Y 122837M 36807M
Eli Lilly And LLY:US $ 5342M 555.1M
Esperion Therapeutics ESPR:US $ 8.85M 30.01M
Exelixis EXEL:US $ 316.55M 53.74M
Gilead Sciences GILD:US $ 6198M 1371M
GlaxoSmithKline GSK:LN 6.26B 682M
Halozyme Therapeutics HALO:US $ 97.24M 16.2M
IONIS PHARMACEUT IONS:US $ 130M 7.21M
Ironwood Pharmaceuticals IRWD:US $ 103.75M 0.28M
Karyopharm Therapeutics KPTI:US $ 37.1M 15.64M
MacroGenics MGNX:US 14M 16.74M
Merk MRK:US $ 10098M 1738M
Nektar Therapeutics NKTR:US $ 19.61M 1.05M
Neurocrine Biosciences NBIX:US $ 291.8M 6M
Novartis NOVN:VX 9.52B 21M
Pfizer PFE:US $ 14163M 2178M
Sarepta Therapeutics SRPT:US $ 165.96M 21.39M
Seattle Genetics SGEN:US $ 341.41M 31.02M
Takeda 4502:JP Y 569023M 139316M
Teva Pharmaceutical TEVA:IT 1.9B 25M
YTE INCY:US $ 778.52M 105.44M